Allogene Therapeutics, Inc.
ALLO
Revenue
0.00
▼-22.00k▼-100.00%
3 Months ChangeAssets
646.88M
▲60.53M▲10.32%
3 Months ChangeLiabilities
131.85M
▲6.86M▲5.49%
3 Months ChangeFree Cash Flow
-55.91M
▲11.77M▲17.39%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-07
Form 8-K
ID: 0001737287-24-000062
2024-08-07
Form 10-Q
ID: 0001737287-24-000056
2024-08-07
Form 8-K
ID: 0001737287-24-000055
2024-06-10
Form 8-K
ID: 0001737287-24-000050
2024-05-31
Form 8-K
ID: 0001737287-24-000046
2024-05-14
Form 8-K
ID: 0001193125-24-138316
2024-05-13
Form 10-Q
ID: 0001737287-24-000041
2024-05-13
Form 8-K
ID: 0001737287-24-000040
2024-03-14
Form 8-K
ID: 0001737287-24-000019
2024-02-16
Form 8-K
ID: 0001193125-24-038107